315701-04-3

Upstream product

• 49615-96-5 1-(3-aminobenzofuran-2-yl)ethan-1-one 
• 315700-88-0 C₁₉H₁₅NO₃ 
• 315700-80-2 C₁₇H₁₃NO₂ 
• 611-20-1 salicylonitrile 
• 49616-03-7 2-acetyl-3-acetamidobenzofuran 
• 100-52-7 benzaldehyde 

Downstream Products

• 1275620-43-3 C₁₉H₁₄BrNO₃ 
• 1275620-44-4 4-chloro-2-phenyl-benzofuro[3,2-b]pyridine 
• 1275620-45-5 C₂₇H₂₆N₂O₆ 
• 1275620-46-6 C₂₃H₂₀N₂O₄ 
• 1275620-47-7 C₃₇H₄₃N₃O₇ 
• 1275620-48-8 C₃₆H₄₁N₃O₇ 
• 1275620-49-9 C₄₅H₅₃N₅O₉S 
• 1275618-99-9 C₄₃H₄₉N₅O₉S 
• 1275620-50-2 C₃₈H₄₁N₅O₇S 
• 1275619-00-5 C₄₄H₄₉N₅O₉S 
• 315701-07-6 2-bromo-3-phenyl-1-(3-acetamido-2-benzofuryl)propen-1-one 

Relevant academic research and scientific papers

HCV PROTEASE INHIBITORS

This invention relates to macrocyclic compounds shown in the specification. These compounds can be used to treat hepatitis C virus infection.

HCV PROTEASE INHIBITORS

This invention relates to macrocyclic compounds of formula (I) shown in the specification. These compounds can be used to treat hepatitis C virus infection.

Synthesis and some reactions of benzofuran analogues of 2-aminochalcones

The synthesis of a series of 1-(3-amino-2-benzofuryl)-3-aryl-2-propen-1-ones 3a-h, the benzofuran analogues of 2-aminochalcones, and their conversion into 2-aryl-1,4-dihydrobenzofuro[2,3-b]pyridin-4-ones 9a-c and 1.2.3.4-tetrahydrobenzofuro[2,3-b] pyridin-4-ones 5a-h by intramolecular Michael addition are reported.